x

RSS Newsfeeds

See all RSS Newsfeeds

Apr 21, 2017 3:00 AM ET

-Global Coronary Stents Market 2017-2021 with Abbott Laboratories, Boston Scientific & Medtronic

iCrowdNewswire - Apr 21, 2017

M2 PRESSWIRE-April 21, 2017-Global Coronary Stents Market 2017-2021 with Abbott Laboratories, Boston Scientific & Medtronic
(C)1994-2017 M2 COMMUNICATIONS

RDATE:21042017

Dublin – Research and Markets has announced the addition of the “Global Coronary Stents Market 2017-2021” report to their offering.

The global coronary stents market to grow at a CAGR of 5.61% during the period 2017-2021.

Global Coronary Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the sales of coronary stents.

According to the report, generally, CROs conduct clinical trials to evaluate the safety and efficacy of coronary stents. However, these organizations are now helping manufacturers in developing these devices. They are also engaging in tie-ups with regulatory agencies for pre- and post-market approvals of stents, which help to minimize the duration of regulatory approvals.

A hybrid procedure is one of the new treatment methods that combines minimally invasive coronary artery bypass surgery (MICABS) with catheter-based coronary intervention. In a bypass surgery, a cardiologist performs angioplasty to restore the normal blood flow in arteries that are not blocked enough to require a bypass. To reduce the chance of re-blockage of the artery, a BMS or DES is used. This method helps to eliminate the plaque deposition in the blood vessels and has fewer after-effects. Since a hybrid procedure involves stenting and a bypass in a single operation, it is cost-effective. This procedure cannot be performed in all cases; the individuals have to be monitored for distal left main coronary artery or proximal left anterior descending CAD, diabetes, systolic dysfunction, surgical risk, and coronary anatomy.

Further, the report states that the development of laser angiography or laser ablation has brought a new and promising treatment for atherosclerosis plaque. Different laser beams like xenon chloride excimer laser, argon, and neodymium: yttrium aluminum garnet with different wavelengths, frequencies, and pulse durations can remove obstructions with minimal damage to the adjacent vessel walls.

Key vendors

– Abbott Laboratories
– Boston Scientific
– Medtronic

Other prominent vendors

– Shandong JW Medical Systems
– Biosensors International Group
– Opto Circuits
– Cook Medical
– Elixir Medical
– Envision Scientific
– LEPU MEDICAL
– Meril Life Sciences

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by products

Part 07: Market segmentation by end-user

Part 08: Geographical segmentation

Part 09: Decision framework

Part 10: Drivers and challenges

Part 11: Market trends

Part 12: Vendor landscape

Part 13: Key vendor analysis

Part 14: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/lzvcc2/global_coronary

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Stents (http://www.researchandmarkets.com/categories.asp?cat_id=243&campaign_id=lzvcc2)


((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.m2.com on the world wide web. Inquiries to info@m2.com)).

Via iCrowdNewswire
Tags: , Wire, M2 Presswire
View Related News >